BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29203282)

  • 1. Modulation of Mcl-1 transcription by serum deprivation sensitizes cancer cells to cisplatin.
    Senichkin VV; Kopeina GS; Prokhorova EA; Zamaraev AV; Lavrik IN; Zhivotovsky B
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):557-566. PubMed ID: 29203282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
    BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.
    Zhang R; Li Y; Dong X; Peng L; Nie X
    Med Oncol; 2014 Dec; 31(12):347. PubMed ID: 25416050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
    Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.
    Cheng D; Xu Y; Sun C; He Z
    Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
    Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
    Han Y; Park S; Kinyua AW; Andera L; Kim KW; Kim I
    Oncol Rep; 2014 Jan; 31(1):456-62. PubMed ID: 24213797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
    Yu Q; Liu ZY; Chen Q; Lin JS
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):494-500. PubMed ID: 27465322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway.
    Liu Z; Zhang YY; Zhang QW; Zhao SR; Wu CZ; Cheng X; Jiang CC; Jiang ZW; Liu H
    Anticancer Drugs; 2014 Apr; 25(4):447-55. PubMed ID: 24492287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
    Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
    Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
    Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation.
    Lirdprapamongkol K; Sakurai H; Abdelhamed S; Yokoyama S; Athikomkulchai S; Viriyaroj A; Awale S; Ruchirawat S; Svasti J; Saiki I
    Int J Oncol; 2013 Jul; 43(1):329-37. PubMed ID: 23636231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
    Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
    Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Bao-Hongluan ; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Jun; 71(6):345-8. PubMed ID: 27455555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
    Nakazato T; Sagawa M; Kizaki M
    Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus.
    You L; Wang Y; Jin Y; Qian W
    Oncol Rep; 2012 Apr; 27(4):971-8. PubMed ID: 22266706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
    Leu CM; Chang C; Hu C
    Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.